Reassuringly, the decline in serum IGF-I with twice-weekly treatment was paralleled by falls in the other elements of the IGF ternary complex, namely IGFBP3 and ALS. The gene discussed is IGFBP3; the disease is amyotrophic lateral sclerosis.